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Abstract 
 The study was aimed at determining the effect of menopause on lipid 
profile. A total of 100 apparently healthy subjects who comprised 50 
menopausal women aged 45 – 77 years and 50 pre-menopausal women 
between the aged between 20-52 years were recruited. Ethical approval was 
obtained from the Faculty of Health Science and Technology, Nnamdi 
Azikiwe University ethics committee and informed consent of each 
participant was obtained prior to recruitment. We estimated serum levels of 
total cholesterol using the enzymatic end point method as described by 
Roeschlau et al., (1974), HDL was performed using the combination of 
phosphotungstate precipitation and enzymatic method as described by 
Burstein et al., (1980), LDL by the combination of polyvinyl sulphate 
precipitation and enzymatic method of Assman et al., (1984), VLDL was 
estimated using the method as described by Friedwald et al., (1972) and 
triglycerides by the enzymatic method as described by Tietz (1990). The 
results shows that the mean levels of serum triglycerides (TG) and low 
density lipoprotein cholesterol (LDL cholesterol) showed a statistically 
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significant increase in menopausal women compared with the pre-
menopausal subjects (P<0.05) while there was no significant difference in 
the mean values of serum high density lipoprotein cholesterol (HDL 
cholesterol), very low density lipoprotein cholesterol (VLDL cholesterol) 
and total cholesterol (P>0.05). There was a progressive increase in the mean 
levels of total cholesterol, triglycerides, LDL-cholesterol and VLDL-
cholesterol with duration of menopause while the levels of HDL-cholesterol 
decreased with duration of menopause. There were no significant variations 
among the various age categories of the menopausal subjects and the levels 
of the lipid parameters studied (p>0.05). The findings suggest that 
premenopausal women have less proatherogenic lipid profile than their 
menopausal counterparts. 
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Introduction 
 Menopause is the permanent cessation of menstruation at the end of 
reproductive life due to loss of ovarian follicular activity (Dutta, 2008). The 
effect of the hormonal changes associated with menopause on the serum 
lipid levels play important roles in most cardiac related disorders associated 
with menopause (Do et al., 2000). Up to the age of 50 years, the prevalence 
of coronary artery disease (CAD) among women is lower than among men, 
but the incidence rises significantly after the menopause. The incidences of 
coronary heart disease have been observed to be increased in 
postmenopausal women until they become similar to the corresponding rates 
in men of similar age (Berg, 2004). Multiple risk factors have been identified 
as contributory to the development of CAD. Hypercholesterolemia is a key 
factor in the pathophysiology of atherosclerosis (Igweh et al., 2005). After 
menopause, there is loss of ovarian function. This results in adverse changes 
in glucose and insulin metabolism, body fat distribution, coagulation, 
fibrinolysis, vascular endothelial dysfunction and also derangement of 
lipoprotein profile. Lack of estrogen is an essential factor in this mechanism 
(Bales, 2000; Samaan and Crawford, 1995).  
 Lipid profile or lipid panel is a panel of blood tests that serves as an 
initial broad medical screening tool for abnormalities in lipids, such as 
cholesterol and triglycerides. The results of this test can identify certain 
genetic diseases and can determine approximate risks for cardiovascular 
diseases, certain forms of pancreatitis and other diseases (Usoro et al., 2006). 
Lipid profile has been proven to be good indicators of whether someone is 
likely to have a heart attack or stroke, caused by blockage of blood vessels or 
hardening of the arteries (atherosclerosis). The lipid profile typically 
includes; total cholesterol (TC), high-density lipoprotein cholesterol (HDL-
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C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG). 
Using these values, very low-density lipoprotein cholesterol (VLDL-C) can 
be calculated (Sidhu and Naugler, 2012). 
 Whether dyslipidemia leads to significant increase in the 
development of coronary artery disease (CAD) is still controversial, more so 
in our environment where little work has been done. The behaviour of 
lipoproteins during the menopausal transition and their relationship with the 
sex hormones and body fat distribution is still unclear (Berg, 2004). Thus, it 
is in view of the above findings that this research was designed to ascertain 
the risk of coronary heart diseases in menopausal women by evaluating the 
lipid profile status in pre-menopausal and post-menopausal women. 
 
Materials and methods 
Study site 
 This research was done in Nnewi metropolis, Nnewi North L.G.A, 
Anambra state, Nigeria.   
 
Study population 
 The study population consisted of 100 apparently healthy subjects 
who comprised 50 menopausal women and 50 pre-menopausal women 
between the age limits of 45-77 and 20-52 respectively. 
 
Inclusion criteria 
 The research study was concerned with postmenopausal women 
between the age limit of 45-77 and premenopausal women between the age 
limit of 20 to 52.   
 
Exclusion criteria 
 The subjects having risk factors that may affect the lipid profile such 
as, diabetes mellitus (DM), neoplasia or other serious pathological disorders, 
those outside the age bracket and those on hormonal replacement therapy 
were excluded.  
 
Ethical consideration 
 The ethical approval for this research was obtained from the Faculty 
of Health Sciences, College of Health Sciences and Technology, Nnamdi 
Azikiwe University, Nnewi Campus Ethics Committee. Informed consent 
was also sought and obtained from the subjects. 
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Collection of samples 
 About 5 ml of venous blood was collected after overnight fasting of 
12 hrs in all the subjects for estimation of serum levels of total cholesterol, 
HDL, LDL, VLDL and triglycerides. Samples were allowed to clot and 
separation performed by centrifugation at 5000rpm for 5minutes. 
 Questionnaires were used to obtain data such as age and menstruation 
status of subjects.  
 
Estimation of total cholesterol (TC) 
 Total cholesterol was determined using the method as described by 
Roeschlau et al., (1974). This is essentially an enzymatic end point method. 
 Procedure: About 10µl of distilled water, cholesterol standard and 
serum were pipetted into the tubes labelled reagent blank, standard and 
sample respectively and 1000µl of reagent pipetted into each of the tubes. 
The tubes were mixed and incubated for 5minutes at 37oC. The absorbance 
of the sample (Asample) and standard (Astandard) were measured against the 
reagent blank within 60minutes at 500nm wavelength. 
 
Calculation 
TC concentration (mmol/l) = Asample x concentration of standard (5.09mmol/l)  
                                            _________________________________ 
                                                                   Astandard      
Estimation of triglycerides 
 The enzymatic method as described by Tietz (1990) was adopted in 
the estimation of triglycerides. 
 
Procedure for triglycerides estimation 
 About 10µl of distilled water, triglyceride standard and serum were 
pipetted into the tubes labelled blank, standard and sample respectively. And 
1000µl of reagent pipetted into each of the tubes which were mixed and 
incubated at 37oC for 5minutes. The absorbance of sample (Asample) and 
standard (Astandard) was measured against the reagent blank within 60minutes 
at 500nm wavelength. 
 
Calculation 
Triglyceride concentration (mmol/l) = Asample x CStandard (2.19mmol/l)  
                                                                 ________________________ 
                                                                         Astandard 
Estimation of high density lipoprotein cholesterol (HDL- C) 
 The estimation of HDL was performed using the method as described 
by Burstein et al., (1980). This is principally a combination of 
phosphotungstate precipitation and enzymatic method. 
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Procedure for HDL estimation 
Stage 1: precipitation 
 About 0.2ml of the subject’s sample was pipetted into the respective 
tubes and 0.5ml of reagent (A) pipetted into each of the tubes. The tubes 
were thoroughly mixed and allowed to stand for 10minutes. Centrifugation 
was done at 4000rpm for 10minutes and the supernatant was then carefully 
collected. 
 
Stage 2: colorimetry 
 About 50µl of HDL-cholesterol standard, sample supernatant and 
distilled water was pipetted into the tubes labelled standard, sample and 
reagent blank respectively and 1.0ml of reagent (B) pipetted into each of the 
tubes. The tubes were thoroughly mixed and incubated for 10minutes at 
37oC. The absorbance of the standard and sample was measured at 500nm 
against the blank. 
 
Calculations 
Concentration of HDL cholesterol (mmol/l): Asample x CStandard (1.36 mmol/l)  
                                                          ___________________________ 
                                                                         Astandard 
Estimation of low density lipoprotein cholesterol (LDL-C) 
 The method of Assman et al., (1984) was adopted. This is a 
combination of polyvinyl sulphate precipitation and enzymatic method. 
 
Procedure of LDL estimation 
Stage 1: precipitation 
 About 0.2ml of subjects’ sample was pipetted into the respective 
tubes and 0.2ml of reagent (A) pipetted into each of the tubes. The tubes 
were thoroughly mixed and allowed to stand for 15minutes at room 
temperature. Centrifugation was done at 4000rpm for 15minutes and the 
supernatant was then carefully collected. 
 
Stage 2: colorimetry 
 About 20µl of distilled water, cholesterol standard and sample 
supernatant was pipetted into the tubes labelled reagent blank, standard and 
sample respectively and  
 1.0ml of reagent (A) pipetted into each of the tubes. The tubes were 
thoroughly mixed and incubated for 10minutes at 37oC. The absorbance of 
the standard and sample was measured at 500nm against the blank. 
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Calculations 
 The cholesterol concentration in the supernatant (CSupernatant) in 
mmol/l was calculated using the following general formula: 
ASample  x Cstandard (5.18mmol/l)      =  CSupernatant  
________________________ 
                          AStandard 
 The LDL cholesterol (mmol/l) in the sample was calculated as 
follows: 
 LDL cholesterol concentration = Total cholesterol – cholesterol in 
supernatant   
 
Estimation of very low density lipoprotein cholesterol (VLDL-C) 
 VLDL-C was estimated using the method as described by Friedwald 
et al., (1972): 
 VLDL-C in sample (mmol/l) = Total cholesterol – (HDL-C + LDL-
C) 
 
Statistical analysis 
 Data generated from the study was subjected to statistical analysis 
using student t-test and ANOVA and presented in table and bar charts. 
Values were deemed significant at p<0.05. 
 
Results 
 In Table 4.1, the mean levels of serum triglycerides and LDL were 
significantly higher in menopausal women compared with the 
premenopausal group (p<0.05) while there was no significant difference in 
the mean values of total cholesterol, HDL and VLDL cholesterol between 
premenopausal and menopausal women (p>0.05).  
 Fig 4.1 shows relationship of the levels of the various lipid 
parameters with the duration of menopause. There was a progressive 
increase in the mean levels of total cholesterol, triglycerides, LDL-
cholesterol and VLDL-cholesterol with duration of menopause while the 
levels of HDL-cholesterol decreased with duration of menopause. 
 Fig 4.2 shows relationship of the levels of the various lipid 
parameters with the various age categories of the menopausal subjects. There 
were no significant variations among the various age categories of the 
menopausal subjects and the levels of the lipid parameters studied (p>0.05).  
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Table 4.1 Comparison of lipid profile in premenopausal and menopausal women 
Parameters              pre-menopausal    menopausal         t-value             p-value 
Mean ± SD         Mean ± SD 
Total cholesterol          3.73 ± 0.96            3.96 ± 1.85             0.767                 0.445 
 
Triglycerides               1.27 ± 0.54             1.54 ± 0.67              2.115                 0.037* 
 
HDL-C                         0.37 ± 0.66            0.25 ± 0.40               1.082                0.282 
 
LDL-C                         2.37 ± 1.06             3.14 ± 1.76               2.632                0.010* 
 
VLDL-C                      0.30 ± 0.23              0.32 ± 0.18               0.620                0.537 
 
 
 
Fig. 4.1 Relationship of the levels of the various lipid parameters with the duration of 
menopause 
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Fig. 4.2 Relationship of the levels of the various lipid parameters with the various age 
categories of the menopausal subjects 
 
Discussion 
 One of the major causes of death among menopausal women is 
cardiovascular disease which accounts for nearly 53% of all deaths in 
women over 50 years of age (Alfonso et al., 2003). Postmenopausal estrogen 
deficiency, hypertriglyceridemia, dyslipoproteinemia and advanced age have 
been described as risk factors for atherosclerosis (Narain et al., 2008) and 
have been associated with increased coronary heart disease (CHD) risk in 
women (Stevenson et al., 1993).  
 In the present study, mean levels of serum triglycerides (TG) and low 
density lipoprotein cholesterol (LDL cholesterol) showed a statistically 
significant increase in menopausal women compared with the pre-
menopausal subjects (P<0.05) while there was no significant difference in 
the mean values of serum high density lipoprotein cholesterol (HDL 
cholesterol), very low density lipoprotein cholesterol (VLDL cholesterol) 
and total cholesterol (P>0.05). This correlates with previous studies by 
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Usoro et al (2006) who found statistically significant increase in levels of 
serum LDL cholesterol and triglycerides after menopause and that of  Igweh 
et al (2005) that observed statistically significant increase in levels of serum 
LDL cholesterol after menopause. However, in contrast to this present study, 
they also found statistically significant decrease in the mean value of HDL 
cholesterol after menopause. This may be related to differences in sample 
sizes. 
 Increased serum triglycerides and LDL-cholesterol levels indicated in 
the results may be due to estrogen related decrease in activity of lipoprotein 
lipase (LPL) after the loss of ovarian function as observed by Stevenson et al 
(1993), Wild et al (1995) and Thomas et al (1998).  
 The concomitant increase in the levels of serum triglycerides and 
LDL-cholesterol in the menopausal group as shown in this present study 
could be attributed to the fact that LDL particles are formed as VLDL 
particles lose triglycerides through the action of lipoprotein lipase (LPL) as 
proposed by Warnick et al (1990) who had earlier reported a correspondence 
between higher triglyceride levels and higher levels of LDL particles. Arca et 
al (1994) had also reported that decrease in estrogen secretion with the 
cessation of ovarian function probably contribute to higher LDL-cholesterol 
level in menopausal women as estrogen increases hepatic synthesis of LDL-
cholesterol receptor for Apo-β100 resulting in increased LDL cholesterol 
uptake and therefore decreases circulating LDL levels. Thus, its deficiency 
results in rise in LDL cholesterol in menopausal women (Wild et al., 1995). 
LDL particles and high levels of triglycerides in the bloodstream have been 
linked to atherosclerosis and, by extension, the risk of heart disease and 
stroke (Nelson and Cox, 2002). Hence, our findings suggest that 
premenopausal women have a less risk of atheroma-formation than their 
menopausal counterparts as proposed by Alfonso et al (2003). 
 Furthermore, there was a significant variation between duration of 
menopause and the levels of the lipid parameters studied (p<0.05). This 
agrees with the findings of Simpson and Davis (2001) and Maulik et al 
(2012). Since many of the factors affecting serum lipid profile were excluded 
in our work, the relation between duration of menopause and the lipid profile 
status could be attributed to progressive depreciation in estrogen levels 
occurring after menopause as observed by Mumford et al. (2010). Reduced 
dietary cholesterol absorption may contribute to the hypocholesterolemic 
effect of estrogen (Karjalainen et al., 2000) and may therefore account for 
the modest increases in the levels of serum total cholesterol after menopause. 
 Estrogen related decrease in the HDL cholesterol concentration after 
menopause may be due to a decrease in the cholesterol content in the large, 
cholesterol-rich HDL2 sub-fraction, likely attributed to augmented 
production rates of HDL apoA-1 with no changes or mild increases in HDL 
European Scientific Journal October 2015 edition vol.11, No.30 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
97 
apoA-1 removal rates (Lamon-Fava et al., 2006). High concentrations of  
HDL have cardio-protective value (Toth and Peter, 2005) while in contrast, 
low level of HDL particles is independently associated with atheromatous 
disease progression in the arteries. Hence, our findings suggest that the risk 
of cardiovascular diseases in menopausal women could be progressive with 
the duration of menopause.  
 There were no significant variations among the various age 
categories of the menopausal subjects and the levels of the lipid parameters 
studied (p>0.05), this suggests that age may not be directly related to the 
severity of lipid disorder after menopause as reported by Hardi and 
Irfanuddin (2007). However, Talat et al., (2003) and Ochei and Kolhatkar 
(2008) provided empirical evidence indicating that serum cholesterol levels 
increase with age. Age has been said to contribute to elevated lipid 
parameters (Estari et al., 2000). This may be associated to the progressive 
decrease in growth hormone (GH) secretion, which occurs with normal aging 
as observed by Corpas et al., (1993). Growth hormone has an important role 
in cholesterol homeostasis (Angelin and Rudling, 1994) both by modulating 
the expression of- hepatic LDL receptors (Parini et al., 1995) and by 
controlling the activity of cholesterol 7∝-hydroxylase (C7∝OH) (Rudling et 
al., 1997). Joanna et al. (2011) had also reported age-mediated reduction in 
5’ adenosine monophosphate-activated protein kinase (AMPK) signaling 
which results in increased intramyocellular lipids. But Hardi and Irfanuddin 
(2007) reported that correlation between age and the alteration in the pattern 
of lipid profile is dependent on obesity and gender. Hence, the contrast in 
this present study could be attributed to the fact that the effect of age on the 
lipid profile status in the menopausal subjects was not investigated in 
relation to their body mass index or other relevant anthropometric measures. 
  
Conclusion  
 Menopause is associated with altered serum lipid profile and thus an 
independent risk factor for developing cardiovascular diseases. The findings 
from this present study show that cardiovascular risk factors like LDL-
cholesterol and triglycerides were significantly increased after menopause 
and progressively increase with the duration of menopause. The data further 
suggest that age may not be directly related to the severity of lipid disorders 
in menopausal women. Hence, menopause is associated with potential 
adverse changes in lipid profile status, independent of any direct effects of 
aging. These changes may in part explain the increased incidence of 
coronary heart disease seen in menopausal women.  
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Recommendations 
 In menopausal women, specific health education strategies are 
needed in order to prevent the incidence of cardiovascular diseases. The 
present study does not show the exact cause of altered serum lipid profile 
after menopause hence, inclusion of estrogen evaluation may help in further 
research. We recommend base-line and frequent determinations of lipid 
profile in menopausal women. This may help in the management and control 
of cardiovascular disorders and other pathological conditions associated with 
alterations in lipid profile in menopausal women.  
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